Future growth is expected to derive from multiple sources, which will include enlarging area serviced by Alpha’s own logistic service resulting in higher number of cooperating private physicians, more laboratory outsourcing contracts from hospitals, an increasing range and sophistication of tests and additional value added services, such as for example, web based availability of test results in close to real time.
From financial performance point of view, Alpha will focus its attention on restructuring its investments and operational cost reduction.
Expansion
Alpha medical Slovakia is able to achieve a strong double digit growth through 2010.Alpha Medical Laboratoria is registering a strong double digit growth with important potential new acquisitions to enlarge its market share strongly on large Polish IVD market.
AM’s expansion team has further identified some important acquisition opportunities in other CEE countries. Recent acquisition (Dec. 2009) of Aeskulab Holding, significant laboratory chain on Czech IVD market, guaranties strong future growth of Alpha medical group.
Project scope
